Market News & Trends
nLife Therapeutics Enters Research Collaboration With WAVE Life Sciences
nLife Therapeutics S.L. recently announced the initiation of a research collaboration aimed at exploring cell-specific targeting of nucleic-acid therapeutics in the central nervous system (CNS)…
Gerresheimer AG Appoints New CEO
Dr. Christian Fischer will join the Management Board of Gerresheimer AG as an ordinary member on August 1, 2017 before taking over as Chief Executive…
Essen BioScience to be Acquired for $320 Million
Essen BioScience Inc., a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research applications, recently signed…
TruTag Technologies & Spinnaker Biosciences Enter Strategic Partnership for Controlled-Release Drug Delivery
TruTag Technologies recently announced it has entered into a strategic partnership with Spinnaker Biosciences for suppling Spinnaker with precision-fabricated nano-porous silica particles (pSi). Spinnaker Biosciences…
Neovacs & BioSense Sign Lucrative Option Agreement
Neovacs recently announced it has signed with BioSense Global LLC a commercial license option agreement for its IFNα Kinoid vaccine to treat lupus and dermatomyositis…
MilliporeSigma Offers Fully Integrated ADC Services to Reduce Complexity, Accelerate Time to Market
MilliporeSigma recently announced it now offers complete and fully integrated services and products for the development and manufacturing of antibody-drug conjugates (ADCs) from gene sequencing…
Mayne Pharma Launches Methylphenidate Extended-Release Capsules in the United States
Mayne Pharma Inc. recently announced the launch of methylphenidate extended-release capsules, 60 mg, in the United States. Methylphenidate is a generic alternative to Ritalin LA…
IDBS & ChemAxon Partnership Extends to Harness Leading Biomolecule Handling Technology
IDBS recently announced that the strategic technology partnership with ChemAxon has been further strengthened. IDBS is now able to leverage ChemAxon’s Biomolecule Toolkit and BioEddie…
Cellect Biotechnology Announces Positive Clinical Trial Results
Cellect Biotechnology Ltd. recently announced positive final results from its clinical trial of ApoGraft in healthy donors. The study’s primary objective was to validate the…
Science-Based Games & Books for Children Demystifies Intimidating Concepts
Genius Games is a publishing company that focuses science-based games, children's books, and toys. We have sold science-based products to over 50 countries globally, with…
Science-Based Games & Books for Children Demystifies Intimidating Concepts
Genius Games is a publishing company that focuses science-based games, children's books, and toys. We have sold science-based products to over 50 countries globally, with…
Catalent Completes Accucaps Acquisition to Expand Softgel Development Manufacturing Capabilities & Capacity
Catalent, Inc. recently announced it has completed the acquisition of Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of OTC, high-potency, and conventional pharmaceutical…
Selecta Biosciences Announces Preclinical Data Showing Potential Benefit in Treatment of Pompe Disease
Selecta Biosciences, Inc. recently announced that results from preclinical studies involving the use of SVP-Rapamycin in combination with alglucosidase alfa (marketed as Myozyme and Lumizyme)…
Vifor Pharma & ChemoCentryx Announce Expansion of Avacopan Agreement
Vifor Pharma and ChemoCentryx, Inc. recently announced that Vifor Pharma has gained rights to commercialize avacopan in Asia, including Japan and the Middle-East. ChemoCentryx retains…
REGENXBIO Announces IND Active for Phase I Trial
REGENXBIO Inc. recently announced the Investigational New Drug application (IND) is active for the planned multi-center, open-label, multiple-cohort, dose-escalation Phase I clinical trial of RGX-314…
NexImmune Acquired by a Consortium of Private Investors Led by Former Celgene & Medtronic CEOs
NexImmune, a biopharmaceutical company developing novel immunotherapeutics based on the Artificial Immune (AIM) nanotechnology platform, recently announced the completion of the acquisition of the company…
Roche to Gain Most as Biogen Remains Leader in Neurodegenerative Drugs Market
Roche will be the biggest mover in the neurodegenerative drugs space throughout the next 5 years, with the anticipated approval of ocrelizumab driving the company’s…
Ascendia Pharmaceuticals Announces Issuance of New Patent for Acute Coronary Syndrome Program
Ascendia Pharmaceuticals, a specialty pharmaceutical company engaged in nano-formulation design, development, and manufacture for poorly soluble molecules, recently announced it has been awarded a new…
Ascendia Pharmaceuticals Announces Issuance of New Patent for Acute Coronary Syndrome Program
Ascendia Pharmaceuticals, a specialty pharmaceutical company engaged in nano-formulation design, development, and manufacture for poorly soluble molecules, recently announced it has been awarded a new…
Pfizer CentreOne Expands Fill-Finish Services
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site. Along…
